Related Experiment Video
Updated: Apr 5, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Early Cardiac Iron Overload in a Child on Treatment of Acute Lymphoblastic Leukemia
Aaron J Reitman1, Thomas D Coates2, David R Freyer3
1Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California; and.
Insights
A boy with Down syndrome and acute lymphoblastic leukemia experienced rapid iron overload in his liver, pancreas, and heart during chemotherapy. This suggests unique factors contribute to iron toxicity in cancer patients beyond typical transfusion-related issues.
Area of Science:
- Hematology
- Oncology
- Pediatrics
Background:
- Acute lymphoblastic leukemia (ALL) treatment can involve intensive chemotherapy regimens.
- Down syndrome is associated with certain medical complexities, including potential cardiac and hepatic issues.
- Iron overload is a known complication, particularly in conditions requiring frequent blood transfusions like hemoglobinopathies.
Observation:
- An 11-year-old boy with Down syndrome and ALL developed hepatic dysfunction after 10 months of treatment.
- Magnetic Resonance Imaging (MRI) demonstrated severe iron deposition in the liver, pancreas, and heart.
- This occurred despite relatively low transfusion exposure and a short treatment duration.
Findings:
- The patient exhibited rapid pancreatic and cardiac iron overload, contrasting with typical patterns seen in hemoglobinopathies.
- Chemotherapy in malignancy may involve unique factors leading to increased free iron and accelerated organ loading.
- This case highlights a potentially distinct mechanism of iron accumulation in pediatric cancer patients.
Implications:
- Standard management of iron overload, informed by hemoglobinopathy experience, may need adaptation for cancer patients.
- Further research is warranted to elucidate the specific mechanisms of chemotherapy-induced iron overload.
- Close monitoring for iron deposition in organs like the heart and pancreas is crucial for pediatric oncology patients undergoing intensive treatment.
Abstract:
An 11-year-old boy with Down syndrome and acute lymphoblastic leukemia developed hepatic dysfunction after only 10 months of treatment. MRI revealed severe iron deposition in the liver, pancreas, and heart. In stark contrast to what is seen in hemoglobinopathies, pancreatic and cardiac iron overload occurred with relatively low transfusion exposure and in a very short time period in this patient. Although extensive experience managing iron overload in hemoglobinopathies informs our approach in other diseases, it is clear that factors not present in hemoglobinopathies may be operative in patients with malignancy undergoing intense chemotherapy that lead to high levels of free iron and rapid loading of the heart and endocrine organs.
